CB
Scientific, Inc, Stock Symbol - CBSC
March 4, 2021 -- InvestorsHub NewsWire -- via Derek McCarthy
-- COVID
was officially declared a national emergency on March 13, 2020.
Immediately, according to OnlineDoctor, Google search interest for
"telehealth" rose by 317%. Simultaneously, Google searches for the
term "doctor near me" dropped by 28% in the U.S. Now that it's
clear Americans are open to at home healthcare services it's up to
us as investors to find great companies in this space for our
portfolios. I have identified two such companies and this article
will introduce them as well as support my opinion that investing in
At Home Healthcare companies should result in a huge profit
potential.
A new wave of
enthusiasm for 'no contact' medicine has taken hold in the United
States and it's in the form of telemedicine and at home remote
monitoring. For patients that are at high risk of Covid-19, going
to the doctor's office can be mixed with fear and concern of
contracting the illness due to the high likelihood of human
contact. Telemedicine and at home remote monitoring are both
solutions to deal with that anxiety. Telemedicine and at home
remote monitoring both significantly reduces the risk of Covid-19
exposure. As a result, many Americans are adopting a positive
attitude toward new technology for being treated and diagnosed at
home.
Telehealth is the distribution of health-related services and
information via electronic information and telecommunication
technologies. It allows long-distance patient and clinician
contact, care, advice, reminders, education, intervention,
monitoring, and remote admissions according to
Wikipedia.
Two companies that
are clearly taking a firm position in the space are 'Face 2 Face
Health', a private childcentric digital health company and CB
Scientific Inc, a public company trading under the stock
ticker CBSC
that is focused on
at home remote monitoring. These two featured companies will
reiterate the foundational argument of this article which is that
medicine in the future is going to be strongly footed in
Telemedicine and at home remote monitoring. Companies that are on
the forefront today are sure to be leaders in the industry tomorrow
and to that end, I as the writer and as an investor feel there is a
tremendous opportunity to make money with developing companies that
personify why at home medical services are an essential part of any
portfolio containing healthcare related
investments.
Face 2 Face Health
is my first featured company and is being used to fortify the point
that this growing trend of Telemedicine is here to stay.
"Children's Health and wellness at your fingertips."
According to the company website (https://f2fhealth.com/),
they seek to improve the health and development and well-being of
every child. Face2Face Health is the first easy to use digital
holistic care coordination and education platform focused primarily
on children and families. Through digital connectivity, they
provide help for a child's physical, developmental, emotional and
behavioral challenges and offer such tools and resources like
screening, remote monitoring, supplements and support
communities.
QUOTE
FROM AMI SHAH, MD, FACP ABAARM:
CB Scientific Inc,
Stock Symbol CBSC,
provides innovative
products and services in the ambulatory non-invasive cardiac remote
monitoring space. Their FDA and CE cleared EKG devices, interactive
cloud-based acquisition software, and smartphone apps for both iOS
and Android platforms, provide improvements in compliance for
patients at risk of abnormal heart rhythms as well as more
scientifically accurate information for physicians. (*) in customer
trials awaiting final CFDA approval. Recently the company announced
they are closing an acquisition (https://cbscientificinc.com/cb-scientific-inc-announces-definitive-agreement-to-acquire-cardiolink-corporation-an-independent-diagnostic-testing-facility-idtf/)
which will streamline their diagnostics by offering both a
diagnosis and treatment recommendations. CBSC
has also announced
that they have new Asian distributors for their My-Cam product, an
auto trigger loop EKG recording device. With that development, the
company then appointed a new director of Asia Pacific named XXX and
Chip Martin as the CEO for CBSC.
This is discussed in a recent podcast (https://audioboom.com/posts/7807543-cb-scientific-inc-discusses-the-potential-of-their-proprietary-cardiac-event-monitor-my-cam-w)
including future revenue projections by June 2021.
Finding the right
investments comes down to understanding the benefits of at home
healthcare and certainly finding the most undervalued opportunities
in the market. I truly believe that CB Scientific Inc. Stock
Symbol CBSC
is, of course,
undervalued and when they start delivering product(s) to their new
Asian distributors later this month, we will see just how impactful
their non invasive cardiac monitor is for people all over the
world. Asia, in particular, has a particularly high rate of heart
disease and globally it already effects 31% of the world's
population. CBSC
is positioned
perfectly to help change early detection and diagnosis which will
save lives and costs due to heart disease.
We have heard from
Doctors like Ami Shah, a board certified and fellowship trained
internal medicine physician who has practiced telemedicine for over
15 years, who believes whole heartily that Telemedicine is the
future and at home remote monitoring is absolutely an integral part
of the overall picture for optimal health and well-being. CB
Scientific, Inc. is a great investment opportunity in my opinion,
and one company that we think you should look at as a potential
investment opportunity. Please read our full disclaimer and
remember to always do your own research of all new investments.
Good luck trading CBSC
and thank you for
reading.
Disclaimer;
INS has been
compensated $50,000 by CB Scientific Inc for digital marketing
services. INS Digital Media is engaged in the business of marketing
and advertising public companies, investment funds and trading
software for companies in return for monetary compensation. Never
invest in any stock featured on this page unless you can afford to
lose your entire investment. INS Digital Media/INS/ Investor News
Source and its employees are not a Registered Investment Advisers,
Broker Dealers, financial analysts or variation of any of these
listed professions or a member of any association. INS is
compensated by third party shareholders from time to time to
feature certain companies, in that even we encourage the company to
issue a press release highlighting such activities on their behalf.
These third parties may have shares and are assumed to liquidate
the company's shares which may very well negatively affect the
stock price. This compensation constitutes a conflict of interest
as to our ability to remain objective in our communication
regarding the profiled company. INS may, from time to time,
purchase shares of public companies that we have been compensated
to feature or profile in the open market and INS does this at fair
market value. Through the use of this advertisement , additional
marketing material, landing pages, social media post or other
affiliated platform marketing presented by Investor News Source
viewing you are using, you agree to hold INS its operators owners
and employees harmless to any and all loss (monetary or otherwise),
damage (monetary or otherwise), or injury (monetary or otherwise)
that you may incur. Trading stock is very risky and you should
never invest unless you are willing to loose your entire
investment. The information contained in publications,
advertisements and published opinions are always based on publicly
available information provided by the featured company and based on
sources which INS and it's members believe to be reliable but that
information is not guaranteed by INS as being accurate and does not
purport to be a complete statement or summary of the Information.
Publications, ads and opinion posts should NOT be considered
financial advice or a solicitation to buy or to stock.
SOURCE: by:
Derek McCarthy
CB Scientific (PK) (USOTC:CBSC)
과거 데이터 주식 차트
부터 2월(2) 2025 으로 3월(3) 2025
CB Scientific (PK) (USOTC:CBSC)
과거 데이터 주식 차트
부터 3월(3) 2024 으로 3월(3) 2025
